127692-13-1|CGI-17341|2,3-Dihydro-2-ethyl-6-nitroimidazo(2,1-b)oxazole|-范德生物科技公司

CGI-17341

NMR下载 COA and HPLC MSDS下载
names：
2,3-Dihydro-2-ethyl-6-nitroimidazo(2,1-b)oxazole
CAS号：
127692-13-1
MDL Number：
MF(分子式)： C7H9N3O3 MW(分子量)： 183.167
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	CGI-17341
英文别名	CGI-17341; CGI 17341; CGI17341.
CAS号	127692-13-1
Inchi	InChI=1S/C7H9N3O3/c1-2-5-3-9-4-6(10(11)12)8-7(9)13-5/h4-5H,2-3H2,1H3
InchiKey	AEKVVFWCBKEYSC-UHFFFAOYSA-N
分子式 Formula	C7H9N3O3
分子量 Molecular Weight	183.167
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	CGI-17341(CAS:127692-13-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	CGI-17341 is an orally active representative of the 5-nitroimidazole series of antimicrobial agents. At concentrations ranging from 0.1 to 0.3 micrograms/ml, CGI 17341 inhibited the drug-susceptible and multi-drug-resistant strains of Mycobacterium tuberculosis. CGI 17341 had no cross-resistance with isoniazid, rifampin, streptomycin, or ethambutol. CGI 17341 is a promising and novel antituberculosis compound with potent in vitro and in vivo activities.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, Norton JE, Daniels L,Dick T, Pang SS, Barry CE 3rd. Identification of a nitroimidazo-oxazine-specificprotein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc NatlAcad Sci U S A. 2006 Jan 10;103(2):431-6. Epub 2005 Dec 30. PubMed PMID:16387854; PubMed Central PMCID: PMC1326169.

[2]Tomioka H. [Prospects for development of new antituberculous drugs]. Kekkaku.2002 Aug;77(8):573-84. Japanese. PubMed PMID: 12235850.

[3] Stover CK, Warrener P, VanDevanter DR, Sherman DR, Arain TM, Langhorne MH,Anderson SW, Towell JA, Yuan Y, McMurray DN, Kreiswirth BN, Barry CE, Baker WR. Asmall-molecule nitroimidazopyran drug candidate for the treatment oftuberculosis. Nature. 2000 Jun 22;405(6789):962-6. PubMed PMID: 10879539.

[4] Ashtekar DR, Costa-Perira R, Nagrajan K, Vishvanathan N, Bhatt AD, Rittel W.In vitro and in vivo activities of the nitroimidazole CGI 17341 againstMycobacterium tuberculosis. Antimicrob Agents Chemother. 1993 Feb;37(2):183-6.PubMed PMID: 8452346; PubMed Central PMCID: PMC187635.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开